Sign in
CompletedPhase 1

Intraoperative Midazolam on Delirium Outcome of Elderly Patients

Key facts

Who runs it
Chinese PLA General Hospital
Where
China5 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 1
People taking part
612 people enrolled
Started
1 Sept 2025
Ended
30 Jun 2026
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Midazolam
  • Saline
Record updated
2 September 2026

Who can take part

Age
65 years to 85 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • 65 ≤ Age ≤ 85 years old
  • Elective surgery under general anesthesia, with an estimated surgery time of ≥ 2 hours
  • Non cardiac surgery, non neurosurgical surgery
  • ASA grades I-III
  • Agree to participate and sign the informed consent form

Who cannot take part

  • Long term use of benzodiazepines before surgery
  • Patients expected to enter the ICU after surgery
  • Preoperative history of comorbidities such as depression and schizophrenia
  • History of neurological disorders, moderate stroke
  • There is cognitive impairment, which is determined based on Mini Mental State Examination (MMSE) scores below the standard threshold
  • There are communication barriers, such as severe dementia, language barriers, and severe hearing or visual impairments
  • There are any contraindications for the use of midazolam (contraindications for patients with severe respiratory dysfunction, patients with severe liver and kidney damage, patients with sleep apnea syndrome, and patients known to be allergic to benzodiazepines)
  • BMI≤18.5/BMI≥30 kg/m2
  • Preoperative severe liver and kidney dysfunction

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study was a multicenter, randomized, double-blind, placebo-controlled trial to treat elderly surgical patients with low-dose midazolam or placebo for anesthesia induction. The incidence of postoperative 7-day delirium was assessed and compared between two groups, to provide valuable reference for clinical practitioners in the use of midazolam in elderly surgical patients.

The 2 groups in the trial

  • Saline groupPlacebo, for comparison

    The control group patients were given 2 mL physiological saline during anesthesia induction.

    Treatment: Saline

  • Midazolam groupTreatment being tested

    The intervention group patients were given 2mg midazolam injection (Jiangsu Enhua Pharmaceutical Co., Ltd.) during anesthesia induction

    Treatment: Midazolam

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Impact of Intraoperative Midazolam on Delirium Outcome of Elderly Patients (I-IMODE): a Multicentre Randomised Controlled Trial
Record updated
2 September 2026